Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  GeneThera, Inc.    GTHR

GENETHERA, INC. (GTHR)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
12/06/2017 12/12/2017 12/14/2017 12/15/2017 12/14/2017 Date
0.0135(c) 0.02(c) 0.019(c) 0(c) 0.019 Last
7 501 68 374 7 301 2 7 301 Volume
+22.73% +48.15% -5.00% -100.00% -5.00% Change
More quotes
Company
GeneThera, Inc. is a biotechnology company.The company is focused on improving food safety by applying the molecular technologies to eradicate zoonotic diseases, such as Johne's, Mad Cow, Chronic Wasting, and E.coli disease.Its product candidate include Herd Guard, a management solution, which... 
More about the company
Latest news on GENETHERA, INC.
2016 Genethera appoints scientific advisor
2016 Genethera secures new laboratory facilities to expand technology platforms
2015 Genethera, inc. issues comments on the first international research symposium..
2015 MYCOBACTERIUM AVIUM PARATUBERCULOSIS : The global warming of the cattle industry
2015 Genethera appoints two new members on its board of directors
2015 GeneThera Enters Into Exclusive Collaboration Agreement with Hudson Robotics ..
2008 GENETHERA INC COM USD0.002 : GeneThera Announces it is Set to Begin Commercial T..
2008 GENETHERA INC COM USD0.002 : GeneThera Releases Results From Initial Animal Test..
2008 GENETHERA INC COM USD0.002 : GeneThera - CHANGING DIRECTIONS - an Update to Shar..
2008 GENETHERA INC COM USD0.002 : STC.UNM Signs License Option Agreement With GeneThe..
More news
Sector news : Biotechnology & Medical Research - NEC
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
More sector news : Biotechnology & Medical Research - NEC
Chart GENETHERA, INC.
Duration : Period :
GeneThera, Inc. Technical Analysis Chart | GTHR | US37185E3062 | 4-Traders
Managers
NameTitle
Antonio Milici Chairman, President & Chief Executive Officer
Tannya L. Irizarry Chief Financial & Administrative Officer
Bruce Winslett Director
Sector and Competitors
1st jan.Capitalization (M$)
GENETHERA, INC.26.67%0
CELLTRION, INC.--.--%23 756
IQVIA HOLDINGS INC34.20%21 227
INCYTE CORPORATION-3.85%20 346
LONZA GROUP59.15%19 523
ALNYLAM PHARMACEUTICALS, INC.235.44%12 349